FDA Approves Bimzelx for Hidradenitis Suppurativa

MONDAY, Nov. 25, 2024-- The U.S. Food and Drug Administration has approved Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate-to-severe hidradenitis suppurativa.Bimzelx becomes the first and only approved medicine designed to...